M. Sester (Homburg, Germany), D. Chesov (Balti, Republic of Moldova), D. Cirillo (Milan, Italy)
Verification of pulmonary tuberculosis in HIV-infected patients with low CD4
A. Lazareva, P. Gavrilov, V. Zhuravlev, E. Reshetneva, P. Yablonskii (St. Petersburg, Russian Federation)
|  |
Impact of social support programme on MDR-TB patients' treatment outcomes
V. Testov, S. Sterlikov, I. Vasilyeva, V. Erokhin, T. Kasayeva (Moscow, Russian Federation)
| |
Adherence to the recommendation of prescribing 4 drugs in the intensive phase of the standard treatment of tuberculosis in Spain
J. M. Garcia-Garcia, T. Rodrigo, M. Casals, J. Ruiz-Manzano, T. Pascual, J. Cayla, G. T. B. Trabajo (Aviles, Barcelona, Gijon, Spain)
|  |
Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases
Y. Yeo, K. W. Jo, S. D. Lee, W. S. Kim, D. S. Kim, T. S. Shim (Seoul, Republic Of Korea)
| |
Effect of vitamin D levels on natural killer cells in diabetes mellitus patients with tuberculosis
M. Ponnana, R. Sivangala, L. Joshi, S. Thada, V. L. Valluri, S. L. Gaddam (Hyderabad, India)
| |
Predictive radiological factors of delayed smear conversion
S. Hafaied, H. Racil, H. Blibech, S. Bacha, S. Cheikh Rouhou, N. Chaouech, A. Chabbou (Tunis, Tunisia)
| |
Predictive factors of recurrent pulmonary tuberculosis
M. Mjid, C. Moussa, S. Toujani, N. Balloum, Y. Ouahchi, N. Ben Salah, A. Ben Hmida, B. Louzir, N. Mhiri, J. Cherif, M. Beji (Tunis, Tunisia)
| |
Gender differences in active tuberculosis
C. Ferreira, T. Pinto, I. Neves, R. Duarte (Coimbra, Aveiro, Porto, Vila Nova de Gaia, Portugal)
| |
Pleural tuberculosis in young people as an indicator of general tuberculosis rate
A. Garcia Zamalloa, J. Taboada Gómez, A. Arrospide Elgerresta, A. Moreno Rodrigo (Mendaro, Spain)
| |
Allelic polymorphism of IL-4 and IL-10 genes as underlying factor in the production of cytokines and rate of recurrent pulmonary tuberculosis(RPTB)
D. Butov, M. Kuzhko, T. Butova, H. Stepanenko (Kharkiv, Kiev, Ukraine)
| |
Usefulness of C-reactive protein and procalcitonin levels in pulmonary tuberculosis
J. Ben Amar, B. Ben Safta, K. Bouzid, B. Dhahri, M. A. Baccar, S. Azzabi, H. Aouina, H. Bouacha (Tunis, Tunisia)
| |
Pharmacokinetic characteristics of ethambutol hydrochloride depending on the way of administration
M. Kuzhko, N. Gulchuk, M. Klimenko, L. Protsyk, O. Avramchuk (Kyiv, Ukraine)
| |
Genotype MTBDR plus Line Probe Assay as a rapid tool for the diagnosis of smear-negative tuberculosis in bronchoalveolar lavage fluid in Pakistan
F. Idrees, M. Irfan, K. Jabeen, R. Hasan (Karachi, Pakistan)
| |